Pain therapeutic - Xgene Pharmaceutical
Latest Information Update: 08 Oct 2020
At a glance
- Originator Xgene Pharmaceutical
- Class Analgesics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Pain
Most Recent Events
- 08 Oct 2020 Investigation in Pain in China (PO) before October 2020 (Xgene Pharmaceutical website, October 2020)